New method may shorten need for blood pressure drug after heart surgery
NCT ID NCT02479529
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a new way to decide when to stop the blood pressure drug norepinephrine in patients who had heart surgery and developed dangerously low blood pressure. The method uses a measure called dynamic arterial compliance to guide the drug reduction. The trial involved 130 adults and compared this approach to standard care. The goal was to see if it could reduce the time patients need the drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- norepinephrine
- What this could lead to
- If successful, this approach could help doctors safely reduce vasopressor use faster after heart surgery, potentially shortening ICU stays.
- What could go wrong
- This is a single-center trial with 130 patients, so results may not apply broadly. The method may not improve outcomes in all settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOPLEGIC SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens-Picardie
Amiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.